Search Results - "Huang, Huai‐Cheng"

Clinical outcomes of cetuximab‐based treatment for distant metastatic head and neck squamous cell carcinoma: A real‐world study using Taiwan Head Neck Society registry database by Lu, Hsueh‐Ju, Hsieh, Meng‐Che, Wang, Hung‐Ming, Hsieh, Jason Chia‐Hsun, Yen, Chia‐Jui, Wu, Shang‐Yin, Huang, Huai‐Cheng, Wang, Hui‐Ching, Chu, Pen‐Yuan, Chen, Tien‐Hua, Chien, Chih‐Yen, Huang, Tai‐Lin, Chang, Yi‐Fang, Hua, Chun‐Hung, Lien, Ming‐Yu, Chen, Jo‐Pai, Lu, Wei‐Chen, Lin, Jin‐Ching, Wang, Chen‐Chi, Liu, Yi‐Chun, Yang, Muh‐Hwa, Lou, Pei‐Jen

“…Background For R/M HNSCC, the differences in prognosis and treatment options between distant metastasis (DM) and locoregional recurrence, especially in the DM…”
Get full text

Outcomes of salvage treatment in patients with recurrent oral squamous cell carcinoma by Chen, Tseng‐Cheng, Lo, Ta‐Hsuan, Huang, Huai‐Cheng, Wang, Chun‐Wei, Yang, Tsung‐Lin, Lou, Pei‐Jen, Ko, Jenq‐Yuh, Wang, Cheng‐Ping

“…Background The survival outcomes of different salvage treatments for patients with recurrent oral cancer remain unclear. Methods A total of 556 patients with…”
Get full text

Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysis by Kao, Hsiang-Fong, Huang, Huai-Cheng, Liao, Bin-Chi, Hong, Ruey-Long

“…The optimal duration of anti-PD-1 for cancer therapy has not been tested, especially when using combination therapy. Epidermal growth factor receptor (EGFR)…”
Get full text

Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis by Lin, Mei-Chun, Leu, Yi-Shing, Chiang, Chun-Ju, Ko, Jenq-Yuh, Wang, Cheng-Ping, Yang, Tsung-Lin, Chen, Tseng-Cheng, Chen, Chun-Nan, Chen, Hsin-Lin, Liao, Chun-Ta, Tsai, Sen-Tien, Lin, Jin-Ching, Chu, Pen-Yuan, Tsai, Kuo-Yang, Tsai, Ming-Hsui, Huang, Huai-Cheng, Yang, Muh-Hwa, Wu, Yuan-Hua, Terng, Shyuang-Der, Chien, Chih-Yen, Liu, Tsang-Wu, Lee, Wen-Chung, Lou, Pei-Jen

“…•Adequate surgical margin for OSCC needs to be re-evaluated.•The study enrolled 15,654 patients with OSCC from the TCR database.•Advanced N stage and positive…”
Get full text

Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis by Kao, Hsiang-Fong, Liao, Bin-Chi, Huang, Yen-Lin, Huang, Huai-Cheng, Chen, Chun-Nan, Chen, Tseng-Cheng, Hong, Yuan-Jing, Chan, Ching-Yi, Chia, Jean-San, Hong, Ruey-Long

“…EGFR pathway inhibition may promote anti-programmed cell death protein 1 (PD-1) responses in preclinical models, but how EGFR inhibition affects tumor antigen…”
Get full text

Recurrent Hepatic Sarcomatoid Carcinoma Cured by Doxorubicin and Ifosfamide Chemotherapy by 林明恩(Ming-En Lin), 黃懷正(Huai-Cheng Huang)

“…Abstract Hepatic sarcomatoid carcinoma is a rare malignant neoplasm composed of both carcinomatous and sarcomatous components. It has a higher risk of relapse…”
Get full text

Dramatic Tumor Shrinkage of Locally Advanced and Inoperable Adenoid Cystic Carcinoma after Intra-arterial Chemotherapy by 薛富仁(Fu-Jen Hsueh), 黃懷正(Huai-Cheng Huang), 洪瑞隆(Ruey-Long Hong)

“…Abstract Adenoid cystic carcinoma is rare and usually arises in the salivary glands. It grows slowly, but is characterized by easy perineural invasion with…”
Get full text

Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen by Yang, Muh-Hwa, Chen, Tien-Hua, Wang, Hung-Ming, Hsieh, Jason Chia-Hsun, Huang, Huai-Cheng, Hsieh, Meng-Che, Yen, Chia-Jui, Wu, Shang-Yin, Hua, Chun-Hung, Lien, Ming-Yu, Chang, Yi-Fang, Wang, Hui-Ching, Chien, Chih-Yen, Huang, Tai-Lin, Lu, Hsueh-Ju, Lin, Jin-Ching, Wang, Chen-Chi, Liu, Yi-Chun, Chen, Jo-Pai, Lu, Wei-Chen, Yiu, Ching-Yi, Lin, Chien-Liang, Lou, Pei-Jen, Chu, Pen-Yuan

“…In recent years, the addition of cetuximab to chemotherapy has improved treatment outcomes for patients with recurrent/metastatic head and neck squamous cell…”
Get full text

RNA binding protein PCBP1 is an intracellular immune checkpoint for shaping T cell responses in cancer immunity by Ansa-Addo, Ephraim A, Huang, Huai-Cheng, Riesenberg, Brian, Iamsawat, Supinya, Borucki, Davis, Nelson, Michelle H, Nam, Jin Hyun, Chung, Dongjun, Paulos, Chrystal M, Liu, Bei, Yu, Xue-Zhong, Philpott, Caroline, Howe, Philip H, Li, Zihai

“…Distinct lineages of T cells can act in response to various environmental cues to either drive or restrict immune-mediated pathology. Here, we identify the RNA…”
Get full text

The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCC by Huang, Huai-Cheng, Huang, Yen-Lin, Chen, Yi-Ju, Wu, Hsin-Yi, Hsu, Chia-Lang, Kao, Hsiang-Fong, Liao, Bin-Chi, Hsieh, Min-Shu, Lin, Neng-Yu, Liao, Yu-Hao, Chen, Hsin-Lin, Chen, Chun-Nan, Chen, Tseng-Cheng, Wang, Cheng-Ping, Yang, Tsung-Lin, Huang, Min-Chuan, Lin, Mei-Chun, Lou, Pei-Jen

“…Immunotherapy has revolutionized cancer treatment, but the lack of a reliable predictive biomarker for treatment response remains a challenge…”
Get full text

Nasopharyngeal Carcinoma Associated with Hemophagocytic Lymphohistiocytosis by Wu, Hsu, Huang, Huai-Cheng

“…Abstract Background Hemophagocytic lymphohistiocytosis (HLH) is a rare disease with high fatality. It can be genetic, or it can be associated with infection,…”
Get full text

Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab by Huang, Huai-Cheng, Cheng, Ann-Lii, Lin, Chung-Wu, Kuo, Sung-Hsin

Get full text

The smart options of induction therapy for locally advanced betel-nuts related HNSCC in Taiwan by Chen, Jo-Pai, Lu, Wei-Chen, Chiang, Keng-Man, Chen, Hsing-wu, Huang, Huai-Cheng, Chang, Chen-Han, Kuo, Sung-Hsin

“…e18080 Background: The treatment of HNSCC in Taiwan is still very challenging and might be related to betel-nuts use. Betel nut chewing might contribute to…”
Get full text

Afatinib and pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma (ALPHA Study): A phase II study with biomarker analysis by Kao, Hsiang-fong, Liao, Bin-Chi, Huang, Yen-Lin, Huang, Huai-Cheng, Chen, Chun-Nan, Chen, Tseng-Cheng, Hong, Yuan-Jing, Chan, Ching-Yi, Hong, Ruey-Long

“…Abstract only 6024 Background: Epidermal growth factor receptor (EGFR) pathway inhibition may synergize with anti-PD1 activity by inhibiting macrophage…”
Get full text

RNA-binding protein PCBP1 shapes tolerance and immune response by constraining the formation of regulatory T cells by Ansa-Addo, Ephraim Abrokwa, Huang, Huai-Cheng, Iamsawat, Supinya, Yu, Xue-Zhong, Howe, Philip H, Li, Zihai

“…Maintaining adequate regulatory T cell (Treg) and effector T cell balance is critical for efficient regulation of tolerance and immune response, respectively…”
Get full text

A real-world study of prognostic factors and risk-stratification model from Taiwanese patients with recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen by Yang, Muh-Hwa, Tien Hua, Chen, Hsieh, Meng-Che, Huang, Huai-Cheng, Chien, Chih-Yen, Huang, Tai-Lin, Hua, Chun-Hung, Lien, Ming-Yu, Wang, Hui-Ching, Lu, Hsueh-Ju, Yen, Chia-Jui, Wu, Shang-Yin, Chen, Jo-Pai, Lu, Wei-Chen, Lin, Jin-Ching, Wang, Chen-Chi, Liu, Yi-Chun, Wang, Hung-Ming, Heieh, Jason, Chia-Hsun, Lou, Pei-Jen

“…e18013 Background: Cetuximab significantly improved survival outcomes of recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) when…”
Get full text

Nasopharyngeal Carcinoma Associated with Jemophagocytic Lymphohistiocytosis by 吳旭(Hsu Wu), 黃懷正(Huai-Cheng Huang)

Get full text

Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab by Huang, Huai-Cheng, Cheng, Ann-Lii, Lin, Chung-Wu, Kuo, Sung-Hsin

Get full text